In 2024, approximately 5,100 people learned they were HIV-positive, and 43% of HIV infections were diagnosed at a late stage, including 27% at an advanced stage. These findings highlight the importance of regular testing and using condoms during sex to control the transmission of sexually transmitted infections (STIs).

STI testing rates continued to rise between 2022 and 2024 thanks to advances in recent years, notably the program offering free, prescription-free laboratory testing for HIV since 2022, which was expanded to include four other STIs (free of charge for those under 26) starting in September 2024.

For World AIDS Day, Santé publique France published a thematic BEH report dedicated to the importance of social determinants in HIV and STI testing and prevention, with a focus on young people. Several studies highlighting social inequalities in sexual health are notably put into perspective. In addition to the national surveillance bulletin on HIV and bacterial STIs, our regional offices publish specific bulletins on regional data.

5,100 people learned they were HIV-positive in 2024

According to the latest national surveillance bulletin on HIV and bacterial STIs, Santé publique France estimated that approximately 5,100 new cases of HIV were recorded in France in 2024. This figure remains stable following an increase between 2020 and 2023.

The number and proportion of young people affected have been rising in recent years. Young people under the age of 24 accounted for approximately 15% of those diagnosed with HIV in 2023.

Trends by Population

Regarding HIV care: among approximately 181,000 people living with HIV in France in 2023, 94% had been diagnosed, and 96% of them were receiving antiretroviral treatment for their HIV infection. Among those receiving treatment, 97% had an undetectable viral load at the threshold of 200 copies per ml and were therefore not infectious to their partners.

Increasing STI Testing and Diagnoses

In 2024, reimbursed testing primarily targeted women, but diagnoses were more frequent among men (including for Chlamydia trachomatis infections). Men who have sex with men also accounted for the majority of syphilis and gonorrhea diagnoses. The incidence of STI diagnoses continued to rise between 2022 and 2024. For syphilis, the incidence among women increased by 24%, with an elevated risk of mother-to-fetus transmission, particularly in the French overseas departments and regions (DROM) where the disease’s incidence is higher.

Among young people aged 15 to 25, gonococcal infections saw the sharpest increase between 2022 and 2024 (+38%). It is also noted that young people aged 18 to 25 accounted for between 44% and 50% of those tested during the first four months of the “Mon-test-IST” program, launched in September 2024 and used by both men and women. The monthly number of young people under 25 tested for HIV via the Mon-test-IST program has doubled.

Targeted prevention for greater effectiveness

Certain groups of people are more exposed to HIV than others and disproportionately so compared to the rest of the population. This is why it is important to implement targeted prevention efforts to provide information on prevention tools (PrEP, condoms) and encourage HIV and STI testing. Among those infected in 2024, 37% were born in sub-Saharan Africa, and heterosexual individuals born abroad account for the majority of new HIV infections. To mark December 1, Santé publique France is relaunching its HIV prevention campaign targeting people from sub-Saharan Africa.

On November 29, Santé publique France also organized the Big Pride Energy Ball 3, a voguing event at Paris City Hall, in partnership with Vers Paris sans sida, specifically for MSM as part of the “Get tested every 3 months!” campaign. This campaign aims to increase the proportion of MSM with multiple partners who get tested quarterly.